New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: PDL BioPharma Inc (NASDAQ:PDLI), Document Security Systems, Inc (NYSEMKT:DSS), Callaway Golf Co (NYSE:ELY), ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
PDL BioPharma Inc (NASDAQ:PDLI) showed a volume of 1.33 million shares by the end of last trade whereas the average volume of the stock remained 2.69 million shares. The stock opened the session at $8.98but then moved to $8.92. At that price, the stock showed a negative performance of -0.67%. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Will PDLI Get Buyers Even After The Recent Rally? Find Out Here
Document Security Systems, Inc (NYSEMKT:DSS) opened the session at $1.53 and closed the session at $1.51. The stock showed a negative performance of -3.21% in previous trading session. Traded with volume of 1.34 million shares in the prior session and the average volume of the stock remained 1.22 million shares. Document Security Systems, Inc. (DSS) develops, markets, secure technologies. The Company specializes in fraud and counterfeit protection for all forms of printed documents and digital information. The Company holds numerous patents for optical deterrent technologies that provide protection of printed information from unauthorized scanning and copying.
Has DSS Found The Bottom And Ready To Gain Momentum? Find Out Here
Callaway Golf Co (NYSE:ELY) opened the session at $8.59 and closed the session at $8.91. The stock showed a positive performance of 3.97% in previous trading session. The beta of the stock remained 1.53. Callaway Golf Company together with its subsidiaries, designs, manufactures and sells golf clubs (drivers, fairway woods, hybrids, irons, wedges and putters) and golf balls, and also sells golf accessories (such as golf bags, golf gloves, headwear, towels,
Why Should Investors Buy ELY After The Recent Gain? Just Go Here and Find Out
ZIOPHARM Oncology Inc (NASDAQ:ZIOP) the stock decreased -2.62% and finished the session at $4.46. Traded with volume of 1.31 million shares in the prior session and the average volume of the stock remained 1.31 million shares. The beta of the stock remained 1.58. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer. The Company's technology employs Intrexon Corporation's RheoSwitch Therapeutic System to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index.
Will ZIOP Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)